Literature DB >> 19378465

Two new test methods to quantify motor deficits in a marmoset model for Parkinson's disease.

Peternella S Verhave1, Raymond A P Vanwersch, Herman P M van Helden, August B Smit, Ingrid H C H M Philippens.   

Abstract

The validity of the common marmoset (Callithrix jacchus) as a model for human disease depends on the development of parameters with clinical relevance. We tested the effect of treatment with MPTP in two newly developed non-invasive motor behavioral paradigms in the context of Parkinson's disease. The "Tower" was designed to quantify the marmoset's natural jumping behavior as a measure for akinesia, the "Hourglass" to test the marmoset's natural righting reflex as measure for rigidity, analogous to axial motor behavior in humans. MPTP treatment affected marmoset behavior in both testing paradigms. The marmoset's righting reflex in the Hourglass remained significantly impaired during the full 3-week period after the MPTP intoxication. In the Tower, the marmosets were not able to jump the largest distances one week after MPTP and showed a persistent reduction in activity during the 3-week period after the MPTP intoxication. Because not all aspects of motor behavior are similarly affected by MPTP, a complete behavioral sketch of parkinsonian marmosets should preferably include a range of motor behavior functions to create an overview of the full range of motor impairments. Both the Hourglass and Tower test provide important behavioral parameters in a clinically relevant multiple testing approach in motor disorder models.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19378465     DOI: 10.1016/j.bbr.2009.01.022

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  16 in total

1.  The marmoset as a model of aging and age-related diseases.

Authors:  Suzette D Tardif; Keith G Mansfield; Rama Ratnam; Corinna N Ross; Toni E Ziegler
Journal:  ILAR J       Date:  2011

2.  Behavioral phenotypes associated with MPTP induction of partial lesions in common marmosets (Callithrix jacchus).

Authors:  Kimberley A Phillips; Corinna N Ross; Jennifer Spross; Catherine J Cheng; Alyssa Izquierdo; K C Biju; Cang Chen; Senlin Li; Suzette D Tardif
Journal:  Behav Brain Res       Date:  2017-02-17       Impact factor: 3.332

3.  Motor assessment of developing common marmosets.

Authors:  Yiwen Wang; Qin Fang; Neng Gong
Journal:  Neurosci Bull       Date:  2014-01-06       Impact factor: 5.203

4.  REM sleep behavior disorder in the marmoset MPTP model of early Parkinson disease.

Authors:  Peternella S Verhave; Marjan J Jongsma; Roland M Van den Berg; José C Vis; Raymond A P Vanwersch; August B Smit; Eus J W Van Someren; Ingrid H C H M Philippens
Journal:  Sleep       Date:  2011-08-01       Impact factor: 5.849

5.  Spinal cord stimulation alleviates motor deficits in a primate model of Parkinson disease.

Authors:  Maxwell B Santana; Pär Halje; Hougelle Simplício; Ulrike Richter; Marco Aurelio M Freire; Per Petersson; Romulo Fuentes; Miguel A L Nicolelis
Journal:  Neuron       Date:  2014-10-30       Impact factor: 17.173

Review 6.  Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models.

Authors:  Roman Chrast; Gesine Saher; Klaus-Armin Nave; Mark H G Verheijen
Journal:  J Lipid Res       Date:  2010-11-09       Impact factor: 5.922

7.  Oral treatment with the NADPH oxidase antagonist apocynin mitigates clinical and pathological features of parkinsonism in the MPTP marmoset model.

Authors:  Ingrid H C H M Philippens; Jacqueline A Wubben; Bente Finsen; Bert A 't Hart
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-17       Impact factor: 4.147

8.  The effects of gestational and chronic atrazine exposure on motor behaviors and striatal dopamine in male Sprague-Dawley rats.

Authors:  Jennifer L Walters; Theresa A Lansdell; Keith J Lookingland; Lisa E Baker
Journal:  Toxicol Appl Pharmacol       Date:  2015-10-09       Impact factor: 4.219

9.  Exogenous LRRK2G2019S induces parkinsonian-like pathology in a nonhuman primate.

Authors:  Nadine Mestre-Francés; Nicolas Serratrice; Aurélie Gennetier; Gina Devau; Sandra Cobo; Stéphanie G Trouche; Pascaline Fontès; Charleine Zussy; Philippe De Deurwaerdere; Sara Salinas; Franck Jd Mennechet; Julien Dusonchet; Bernard L Schneider; Isabella Saggio; Vasiliki Kalatzis; M Rosario Luquin-Piudo; Jean-Michel Verdier; Eric J Kremer
Journal:  JCI Insight       Date:  2018-07-26

Review 10.  Neurobehavioral development of common marmoset monkeys.

Authors:  Nancy Schultz-Darken; Katarina M Braun; Marina E Emborg
Journal:  Dev Psychobiol       Date:  2015-10-26       Impact factor: 3.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.